PED rules violation led to an 80-game suspension for Toronto Blue Jays player Orelvis Martinez a few days after his MLB debut.
Orelvis Martinez, an infielder with the Toronto Blue Jays, was suspended for 80 games without pay for breaking the league’s performance-enhancing drug policy just a few days after making his Major League Baseball (MLB) debut.
The 22-year-old tested positive for clomiphene, a fertility medication that is on the league’s list of prohibited substances, according to MLB.
After visiting a fertility clinic in his home Dominican Republic over the winter, Martinez, who made his big league debut on Friday and recorded his first career hit in the team’s 7-1 loss to the Cleveland Guardians, stated that he had been trying to start a family with his girlfriend for the previous two years and was prescribed Rejun 50, which contains clomiphene.
Martinez said in a statement made available by the MLB Players Association, “We wanted to keep this matter private, even within our family, and trusted the doctor who assured us this treatment did not include performance-enhancing drugs.” I therefore erred in not telling my team or the MLBPA about this.
Having said that, I accepted my suspension and fully owned up to my carelessness. I’ll take what I’ve learned from it and return to the field in September. On June 21, Martinez takes the bat in the third inning against the Cleveland Guardians.
Martinez, who joined the team’s Triple-A club Buffalo Bisons this season after being signed as an international free agent in 2018, hit.260 with 14 home runs and 46 RBIs.
According to a statement released by the Blue Jays executive vice president and general manager Ross Atkins, “we were both surprised and disappointed to learn of Orelvis Martinez’s suspension.” “We’ll use every effort to make sure Elvis has learned from this error. We are rooting for Elvis, and we are confident he will overcome this.